Cost-Minimisation Analysis of Dapagliflozin Compared To Lixisenatide As An Add-On To Insulin In The Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective
Value Health. 2014 Nov;17(7):A348.
doi: 10.1016/j.jval.2014.08.717.
Epub 2014 Oct 26.